{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:36:04Z","timestamp":1787016964302,"version":"build-2736575974"},"reference-count":31,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2025,4,4]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The role of intravenous magnesium sulfate in asthma exacerbation is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To determine the efficacy and safety of intravenous magnesium sulfate in managing asthma exacerbation in children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched MEDLINE, EMBASE, CINAHL, the Cochrane Central Register of Controlled Trials and the Web of Science up to May 2024. We included randomised controlled trials and followed the international guidelines for conducting systematic reviews. Outcomes included morbidity, escalation of care, length of hospital stay, lung functions, adverse events, and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine studies (total participants=473) were included. Hospitalisation rate and the need for non-invasive ventilation were less among the intravenous magnesium sulfate group (mean difference (MD)=0.70, 95% CI 0.54 to 0.90, I\n                      <jats:sup>2<\/jats:sup>\n                      7%, n=115) and (risk ratio (RR)=0.17, 95%\u2009CI 0.15 to 0.54, p=0.003, n=143), respectively. Asthma severity scores (MD=\u22120.18, 95%\u2009CI \u22121.35 to 0.98, I\n                      <jats:sup>2<\/jats:sup>\n                      2%, n=115), length of hospital stay (MD=\u221278.86, 95%\u2009CI \u2212200.37 to 42.66, I\n                      <jats:sup>2<\/jats:sup>\n                      99%, n=284) and the need for invasive ventilation (RR=0.35, 95% CI 0.11 to 1.17, I\n                      <jats:sup>2<\/jats:sup>\n                      0%, n=237) were similar. There was no difference in the Paediatric Intensive Care Unit (PICU) admission rate (p=0.43 n=61). Peak expiratory flow improved in the intravenous magnesium group (p&lt;0.001, n=20). No serious adverse events were reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We found low-certainty evidence that intravenous magnesium sulfate results in a lower hospitalisation rate and less need for non-invasive ventilation. Asthma scores, PICU admission, invasive ventilation and length of hospital stay were similar. While the evidence base is weak, the favourable safety profile suggests that intravenous magnesium sulfate can be considered a treatment for asthma exacerbations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42023405261.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/archdischild-2024-327486","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T21:10:30Z","timestamp":1750885830000},"page":"955-961","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Use of intravenous magnesium sulfate in addition to standard first-line treatment with inhaled\/nebulised short-acting beta 2 agonist and systemic steroids in the management of acute asthma exacerbations in children: a systematic review and meta-analyses of randomised controlled trials"],"prefix":"10.1136","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1803-2820","authenticated-orcid":false,"given":"Ali Abdalla","family":"Hamud","sequence":"first","affiliation":[{"name":"Sidra Medicine, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0974-1302","authenticated-orcid":false,"given":"Khalid","family":"Mudawi","sequence":"additional","affiliation":[{"name":"Emergency Department, Sidra Medicine Department of Emergency Medicine, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8181-875X","authenticated-orcid":false,"given":"Colin","family":"Powell","sequence":"additional","affiliation":[{"name":"Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Alsaleh","sequence":"additional","affiliation":[{"name":"Sidra Medicine, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadan","family":"Salem","sequence":"additional","affiliation":[{"name":"Sidra Medicine, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Alnasif","sequence":"additional","affiliation":[{"name":"Sidra Medicine, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Tonbari","sequence":"additional","affiliation":[{"name":"Sidra Medicine, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"Zou Zou","sequence":"additional","affiliation":[{"name":"Sidra Medicine, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham","family":"Alhaji","sequence":"additional","affiliation":[{"name":"Sidra Medicine, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6718-5228","authenticated-orcid":false,"given":"Abdul Kareem","family":"Pullattayil","sequence":"additional","affiliation":[{"name":"Queens Library, Queen\u2019s University, Kingston, Ontario, Canada"},{"name":"Clinical Library, Sidra Medical and Research Center, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8676-0953","authenticated-orcid":false,"given":"Ibtihal Siddiq","family":"Abdelgadir","sequence":"additional","affiliation":[{"name":"Pediatrics, Sidra Medical and Research Center, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"2025111903363270000_110.12.955.1","unstructured":"WHO . Integrated management of childhood illness (IMCI) chart booklet [IBN]. n.d. Available: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/104772\/9789241506823_Chartbook_eng.pdf"},{"key":"2025111903363270000_110.12.955.2","unstructured":"WHO . Pocket book of hospital care for children: guidelines for managing common childhood illnesses\u20132nd ed. ISBN 978 92 4 154837 3. Available: https:\/\/www.who.int\/publications\/i\/item\/978-92-4-154837-3"},{"key":"2025111903363270000_110.12.955.3","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.12.04052","article-title":"Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study","volume":"12","author":"Song","year":"2022","journal-title":"J Glob Health"},{"key":"2025111903363270000_110.12.955.4","unstructured":"World Health Organization . Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. 2007. Available: http:\/\/www.who.int\/gard\/publications\/GARD_Manual\/en\/"},{"key":"2025111903363270000_110.12.955.5","unstructured":"United Nations Inter Agency Group for Child Mortality Estimation (UNIGME) . \u2018Levels & trends in child mortality: report 2020 estimates developed by the United Nations inter agency group for child mortality estimation. New York United Nations Children\u2019s Fund; 2020."},{"key":"2025111903363270000_110.12.955.6","unstructured":"Global Initiative for Asthma . Global strategy for asthma management and prevention. 2022. Available: http:\/\/www.ginasthma.org\/local\/uploads\/files\/"},{"key":"2025111903363270000_110.12.955.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.09.029"},{"key":"2025111903363270000_110.12.955.8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5935\/0103-507X.20160064","article-title":"Contemporary treatment of children with critical and near-fatal asthma","volume":"28","author":"Shein","year":"2016","journal-title":"Rev Bras Ter Intensiva"},{"key":"2025111903363270000_110.12.955.9","article-title":"Inhaled magnesium sulfate in the treatment of acute asthma","volume":"12","author":"Powell","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025111903363270000_110.12.955.10","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-306186"},{"key":"2025111903363270000_110.12.955.11","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0000000000000909"},{"key":"2025111903363270000_110.12.955.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025111903363270000_110.12.955.13","unstructured":"Review manager (RevMan) 5.4.1 [computer program]. Version 5.4. Copenhagen The Nordic Cochrane Centre, The Cochrane Collaboration; 2020."},{"key":"2025111903363270000_110.12.955.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2025111903363270000_110.12.955.15","unstructured":"Deeks JJ , Higgins JPT , Altman DG , et al . Chapter 10: analysing data and undertaking meta-analyses. In: Higgins JPT , Thomas J , Chandler J , et al , eds. Cochrane handbook for systematic reviews of interventions version 6.3. Cochrane, 2022. Available: www.training.cochrane.org\/handbook"},{"key":"2025111903363270000_110.12.955.16","unstructured":"Page MJ , Higgins JPT , Sterne JAC , et al . Chapter 13: assessing risk of bias due to missing results in a synthesis. In: Higgins JPT , Thomas J , Chandler J , et al , eds. Cochrane handbook for systematic reviews of interventions version 6.3. Cochrane, 2022. Available: www.training.cochrane.org\/handbook"},{"key":"2025111903363270000_110.12.955.17","unstructured":"Sch\u00fcnemann HJ , Higgins JPT , Vist GE , et al . Chapter 14: completing \u2018summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT , Thomas J , Chandler J , et al , eds. Cochrane handbook for systematic reviews of interventions version 6.3. 2022."},{"key":"2025111903363270000_110.12.955.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70023-9"},{"key":"2025111903363270000_110.12.955.19","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.154.10.979"},{"key":"2025111903363270000_110.12.955.20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01579-2017","article-title":"Intravenous magnesium sulfate for acute wheezing in young children: a randomised double-blind trial","volume":"51","author":"Pruikkonen","year":"2018","journal-title":"Eur Respir J"},{"key":"2025111903363270000_110.12.955.21","first-page":"291","article-title":"Effectiveness of magnesium sulfate as initial treatment of acute severe asthma in children, conducted in a tertiary-level university hospital: a randomized, controlled trial","volume":"110","author":"Torres","year":"2012","journal-title":"Arch Argent Pediatr"},{"key":"2025111903363270000_110.12.955.22","first-page":"389","article-title":"Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy","volume":"34","author":"Devi","year":"1997","journal-title":"Indian Pediatr"},{"key":"2025111903363270000_110.12.955.23","doi-asserted-by":"publisher","DOI":"10.1097\/00063110-199909000-00005"},{"key":"2025111903363270000_110.12.955.24","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000581"},{"key":"2025111903363270000_110.12.955.25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2223\/JPED.235","article-title":"Estudo controlado do uso endovenoso de sulfato de magn\u00e9sio ou de salbutamol no tratamento precoce da crise de asma aguda grave em crian\u00e7as [Randomized clinical trial of intravenous magnesium sulfate versus salbutamol in early management of severe acute asthma in children]","volume":"77","author":"Santana","year":"2001","journal-title":"J Pediatr (Rio J)"},{"key":"2025111903363270000_110.12.955.26","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2000.111060"},{"key":"2025111903363270000_110.12.955.27","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1984.02140440058015"},{"key":"2025111903363270000_110.12.955.28","article-title":"Intravenous magnesium sulfate for treating children with acute asthma in the emergency department","volume":"4","author":"Griffiths","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025111903363270000_110.12.955.29","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.050005"},{"key":"2025111903363270000_110.12.955.30","doi-asserted-by":"crossref","unstructured":"Rowe BH , Bretzlaff J , Bourdon C , et al . Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000;2016. doi:10.1002\/14651858.CD001490","DOI":"10.1002\/14651858.CD001490"},{"key":"2025111903363270000_110.12.955.31","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2023.1211949","article-title":"Magnesium sulfate treatment for acute severe asthma in adults-a systematic review and meta-analysis","volume":"4","author":"Rovsing","year":"2023","journal-title":"Front Allergy"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2024-327486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:37:27Z","timestamp":1763552247000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2024-327486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,11,19]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/archdischild-2024-327486"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2024-327486","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}